Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03127631

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
6,000 (estimated)
Sponsor
McMaster University · Academic / Other
Sex
Male
Age
45 Years
Healthy volunteers
Not accepted

Summary

RADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate cancer. RADICAL PC2 is a randomized, controlled trial of a systematic approach to modifying cardiovascular and lifestyle risk factors in men with a new diagnosis of prostate cancer.

Detailed description

RADICAL PC describes two prospective studies, one of which is embedded in the other. RADICAL PC1 is a prospective cohort study of men within one year of their first diagnosis of prostate cancer, or treated with Androgen Deprivation Therapy for the first time within 6 months prior to enrollment visit, or to be treated with Androgen Deprivation Therapy for the first time within one month after the enrollment visit. Its goal will be to identify factors associated with the development of cardiovascular disease among men with prostate cancer, with a particular focus on Androgen Deprivation Therapy. RADICAL PC2 is a randomized, controlled trial embedded in RADICAL PC1. RADICAL PC2 will test a systematic approach to modifying cardiovascular and lifestyle risk factors in men within one year of their first diagnosis of prostate cancer, or treated with Androgen Deprivation Therapy for the first time within 6 months prior to enrollment visit, or to be treated with Androgen Deprivation Therapy for the first time within one month after the enrollment visit.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNutritionStandardized advice on healthy diet practices.
BEHAVIORALExerciseStandardized advice on exercise including strength training and resistance training exercises.
BEHAVIORALSmoking cessationAdvice to quit smoking, if applicable, and on available aids to quit smoking,
DRUGStatin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)Prescription for a low to moderate dose statin, such as simvastatin 10-40mg daily, atorvastatin 10-40mg daily, rosuvastatin 5-20mg daily or pravastatin 10-40mg daily.
DRUGACE inhibitorPrescription for an ACE-I (preferable) or an angiotensin receptor blocker for baseline systolic blood pressure greater \>130mmHg, or other blood pressure lowering medication as applicable.

Timeline

Start date
2015-10-21
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2017-04-25
Last updated
2025-01-31

Locations

54 sites across 7 countries: United States, Australia, Brazil, Canada, Colombia, Israel, Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03127631. Inclusion in this directory is not an endorsement.